#Japan #Tokyo #Vault CRM #Astellas Pharma #Veeva

A New Era for Astellas Pharma with Veeva Vault CRM

In a significant strategic move, Astellas Pharma has announced its decision to adopt Veeva Vault CRM as a global standard for its commercial operations. This adoption, which includes the implementation of Veeva China CRM specifically for the Chinese market, is set to enhance Astellas’ agility and operational effectiveness. The announcement was made by Veeva Systems【NYSE:VEEV】, which specializes in cloud software tailored for the life sciences industry.

Nick Eshkenazi, the Chief Digital & Transformation Officer of Astellas Pharma, elaborated on the importance of this change by stating, "Astellas Pharma creates innovative pharmaceuticals for patients around the globe. A robust foundation which supports agility and operational execution in our commercial functions is of utmost importance. Veeva’s technology solutions and data will help us strengthen our corporate agility, as they share our values and patient-centered approach."

This collaboration between Astellas Pharma and Veeva symbolizes a commitment to optimizing health outcomes worldwide through innovative solutions in healthcare. Matt Farrell, Veeva’s President of Commercial Strategy, highlighted the impact of this partnership, asserting the role of Astellas Pharma as an industry leader dedicated to improving global health via innovative science and healthcare solutions. He expressed optimism for deepening this partnership through the capabilities offered by Veeva Vault CRM, which is expected to play a crucial role in supporting Astellas' mission.

Veeva Vault CRM stands out as a solution that adapts to the unique business needs and compliance requirements prevalent in the healthcare industry across different countries. As a part of the Vault CRM Suite, it facilitates seamless collaboration among sales, marketing, and medical departments within the life sciences sector. This not only enhances communication but also enables more effective medical information dissemination.

Veeva Systems operates globally, serving nearly 1,400 customers ranging from some of the largest pharmaceutical companies to emerging biotech firms. They provide comprehensive services that span from drug development to commercial operations, uniquely positioning themselves in the healthcare ecosystem. Additionally, Veeva holds the distinction of being the first publicly traded corporation designated as a Public Benefit Corporation. This means they are committed to balancing the interests of all stakeholders, including customers, employees, partners, shareholders, and the broader service industry.

As Astellas continues to innovate in the pharmaceutical landscape, the partnership with Veeva represents a commitment to leveraging advanced technology to achieve significant health improvements for patients globally. The adoption of Veeva Vault CRM is not merely a shift in tools; it’s a step towards a more integrated, responsive, and efficient approach to commercial operations that aligns with the core mission of Astellas Pharma.

To learn more about Veeva Systems and their offerings, visit www.veeva.com/jp/. For real-time updates, follow Veeva on LinkedIn at jp.linkedin.com/company/veeva-japan.

About Veeva Systems

Veeva Systems is a leading global company providing cloud solutions tailored for the life sciences industry. With its services, they connect customers with the latest tools to streamline their operations across the pharmaceutical and biotechnology sectors, ensuring they remain at the forefront of innovation.

Disclaimer

This release incorporates forward-looking statements regarding Veeva’s products and anticipated results or benefits. Actual outcomes may differ significantly from those presented here, and Veeva does not undertake to update these statements. For a detailed list of risks that may impact their business, refer to Veeva’s Form 10-Q filings.